- Home
- BWLP vs LGND Comparison
BWLP vs LGND Comparison
Compare BWLP & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- LGND
- Stock Information
- Founded
- BWLP 1935
- LGND 1987
- Country
- BWLP Singapore
- LGND United States
- Employees
- BWLP N/A
- LGND N/A
- Industry
- BWLP Marine Transportation
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- LGND Health Care
- Exchange
- BWLP Nasdaq
- LGND Nasdaq
- Market Cap
- BWLP 1.8B
- LGND 2.2B
- IPO Year
- BWLP N/A
- LGND 1992
- Fundamental
- Price
- BWLP $11.24
- LGND $107.62
- Analyst Decision
- BWLP
- LGND Strong Buy
- Analyst Count
- BWLP 0
- LGND 6
- Target Price
- BWLP N/A
- LGND $145.00
- AVG Volume (30 Days)
- BWLP 450.1K
- LGND 135.2K
- Earning Date
- BWLP 02-27-2025
- LGND 05-06-2025
- Dividend Yield
- BWLP 21.44%
- LGND N/A
- EPS Growth
- BWLP N/A
- LGND N/A
- EPS
- BWLP 2.64
- LGND N/A
- Revenue
- BWLP $3,563,747,000.00
- LGND $167,133,000.00
- Revenue This Year
- BWLP N/A
- LGND $16.90
- Revenue Next Year
- BWLP $3.27
- LGND $18.27
- P/E Ratio
- BWLP $4.74
- LGND N/A
- Revenue Growth
- BWLP 20.91
- LGND 27.28
- 52 Week Low
- BWLP $9.95
- LGND $67.72
- 52 Week High
- BWLP $22.31
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- BWLP 46.47
- LGND 44.36
- Support Level
- BWLP $10.88
- LGND $106.79
- Resistance Level
- BWLP $11.85
- LGND $112.49
- Average True Range (ATR)
- BWLP 0.29
- LGND 4.58
- MACD
- BWLP 0.06
- LGND 0.12
- Stochastic Oscillator
- BWLP 68.07
- LGND 43.87
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.